{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,30]],"date-time":"2026-08-30T00:05:16Z","timestamp":1788048316638,"version":"build-2784847793"},"reference-count":67,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2022,5]]},"DOI":"10.1016\/j.ejmech.2022.114278","type":"journal-article","created":{"date-parts":[[2022,3,17]],"date-time":"2022-03-17T13:06:15Z","timestamp":1647522375000},"page":"114278","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"special_numbering":"C","title":["Amphiphilic cyclic peptide [W4KR5]-Antibiotics combinations as broad-spectrum antimicrobial agents"],"prefix":"10.1016","volume":"235","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0988-014X","authenticated-orcid":false,"given":"Eman H.M.","family":"Mohammed","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandeep","family":"Lohan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rakesh K.","family":"Tiwari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8600-0893","authenticated-orcid":false,"given":"Keykavous","family":"Parang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2022.114278_bib1","doi-asserted-by":"crossref","first-page":"183","DOI":"10.3389\/fmed.2017.00183","article-title":"Infections caused by antimicrobial drug-resistant saprophytic gram-negative bacteria in the environment","volume":"4","author":"Raphael","year":"2017","journal-title":"Front. Med."},{"key":"10.1016\/j.ejmech.2022.114278_bib2","doi-asserted-by":"crossref","first-page":"129","DOI":"10.3855\/jidc.3573","article-title":"Bacteriophage therapy: a potential solution for the antibiotic resistance crisis","volume":"8","author":"Golkar","year":"2014","journal-title":"J.\u00a0Infect. Dev. Ctries."},{"key":"10.1016\/j.ejmech.2022.114278_bib3","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1038\/s41573-019-0058-8","article-title":"Antimicrobial host defence peptides: functions and clinical potential","volume":"19","author":"Mookherjee","year":"2020","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ejmech.2022.114278_bib4","doi-asserted-by":"crossref","first-page":"1805092","DOI":"10.1002\/adma.201805092","article-title":"Supramolecular antibacterial materials for combatting antibiotic resistance","volume":"31","author":"Li","year":"2019","journal-title":"Adv. Mater."},{"key":"10.1016\/j.ejmech.2022.114278_bib5","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1126\/science.1176667","article-title":"Antibiotics for emerging pathogens","volume":"325","author":"Fischbach","year":"2009","journal-title":"Science"},{"key":"10.1016\/j.ejmech.2022.114278_bib6","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1086\/652237","article-title":"The 10 x '20 Initiative: pursuing a global commitment to develop 10 new antibacterial drugs by 2020","volume":"50","year":"2010","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.ejmech.2022.114278_bib7","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2014.00551","article-title":"A\u00a0new strategy to fight antimicrobial resistance: the revival of old antibiotics","volume":"5","author":"Cassir","year":"2014","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.ejmech.2022.114278_bib8","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1038\/nrmicro1098","article-title":"Antimicrobial peptides: pore formers or metabolic inhibitors in bacteria?","volume":"3","author":"Brogden","year":"2005","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.ejmech.2022.114278_bib9","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2019.02866","article-title":"Mechanisms of action for antimicrobial peptides with antibacterial and antibiofilm functions","volume":"10","author":"Raheem","year":"2019","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.ejmech.2022.114278_bib10","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2019.01688","article-title":"Evaluation of the antimicrobial peptide, RP557, for the broad-spectrum treatment of wound pathogens and biofilm","volume":"10","author":"Woodburn","year":"2019","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.ejmech.2022.114278_bib11","first-page":"61","article-title":"Intracellular targeting mechanisms by antimicrobial peptides","author":"Le","year":"2017","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2022.114278_bib12","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1038\/s41579-019-0288-0","article-title":"The global preclinical antibacterial pipeline","volume":"18","author":"Theuretzbacher","year":"2020","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.ejmech.2022.114278_bib13","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1038\/nrmicro2095","article-title":"Antimicrobial peptides: linking partition, activity and high membrane-bound concentrations","volume":"7","author":"Melo","year":"2009","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.ejmech.2022.114278_bib14","doi-asserted-by":"crossref","first-page":"183443","DOI":"10.1016\/j.bbamem.2020.183443","article-title":"Interactions of \"de novo\" designed peptides with bacterial membranes: implications in the antimicrobial activity","volume":"1862","author":"Maturana","year":"2020","journal-title":"Biochim. Biophys. Acta Biomembr."},{"key":"10.1016\/j.ejmech.2022.114278_bib15","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/j.carres.2011.01.015","article-title":"Synthesis and antibacterial activity of amphiphilic lysine-ligated neomycin B conjugates","volume":"346","author":"Bera","year":"2011","journal-title":"Carbohydr. Res."},{"key":"10.1016\/j.ejmech.2022.114278_bib16","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0039768","article-title":"Enhanced membrane pore formation through high-affinity targeted antimicrobial peptides","volume":"7","author":"Arnusch","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.ejmech.2022.114278_bib17","doi-asserted-by":"crossref","first-page":"108","DOI":"10.2174\/1567201811666140910094050","article-title":"Levofloxacin and indolicidin for combination antimicrobial therapy","volume":"12","author":"Ghaffar","year":"2015","journal-title":"Curr. Drug Deliv."},{"key":"10.1016\/j.ejmech.2022.114278_bib18","doi-asserted-by":"crossref","first-page":"2505","DOI":"10.1021\/acs.molpharmaceut.5b00053","article-title":"Bacteria-targeting conjugates based on antimicrobial peptide for bacteria diagnosis and therapy","volume":"12","author":"Chen","year":"2015","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ejmech.2022.114278_bib19","doi-asserted-by":"crossref","first-page":"7237","DOI":"10.1038\/s41598-018-25714-z","article-title":"Synergistic combination of two antimicrobial agents closing each other's mutant selection windows to prevent antimicrobial resistance","volume":"8","author":"Xu","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejmech.2022.114278_bib20","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1378\/chest.128.2.940","article-title":"The controversy of combination vs monotherapy in the treatment of hospitalized community-acquired pneumonia","volume":"128","author":"Weiss","year":"2005","journal-title":"Chest"},{"key":"10.1016\/j.ejmech.2022.114278_bib21","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1128\/CMR.05041-11","article-title":"Combination therapy for treatment of infections with gram-negative bacteria","volume":"25","author":"Tamma","year":"2012","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.ejmech.2022.114278_bib22","doi-asserted-by":"crossref","DOI":"10.1002\/med.21879","article-title":"Antimicrobial peptides, conventional antibiotics, and their synergistic utility for the treatment of drug-resistant infections","author":"Zhu","year":"2022","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.ejmech.2022.114278_bib23","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1097\/00006454-199907000-00004","article-title":"Prospective, randomized, investigator-blinded study of the efficacy and safety of meropenem vs. cefotaxime therapy in bacterial meningitis in children. Meropenem Meningitis Study Group","volume":"18","author":"Odio","year":"1999","journal-title":"Pediatr. Infect. Dis. J."},{"key":"10.1016\/j.ejmech.2022.114278_bib24","series-title":"Infectious Disease and Pharmacology","first-page":"155","article-title":"Chapter 13 - antibiotic considerations for necrotizing enterocolitis","author":"Rochon","year":"2019"},{"key":"10.1016\/j.ejmech.2022.114278_bib25","first-page":"23","article-title":"Design, synthesis, and evaluation of amphiphilic cyclic and linear peptides composed of hydrophobic and positively-charged amino acids as antibacterial agents","author":"Riahifard","year":"2018","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2022.114278_bib26","doi-asserted-by":"crossref","first-page":"3528","DOI":"10.1021\/mp5003027","article-title":"Antibacterial activities of amphiphilic cyclic cell-penetrating peptides against multidrug-resistant pathogens","volume":"11","author":"Oh","year":"2014","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ejmech.2022.114278_bib27","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.01677","article-title":"Cyclic peptide [R4W4] in improving the ability of first-line antibiotics to inhibit Mycobacterium tuberculosis inside in\u00a0vitro human granulomas","volume":"11","author":"Hernandez","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ejmech.2022.114278_bib28","doi-asserted-by":"crossref","first-page":"957","DOI":"10.3390\/molecules22060957","article-title":"Synthesis and evaluation of antimicrobial activity of [R4W4K]-Levofloxacin and [R4W4K]-Levofloxacin-Q conjugates","volume":"22","author":"Riahifard","year":"2017","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2022.114278_bib29","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.ijpharm.2007.08.023","article-title":"Thermal and alkaline stability of meropenem: degradation products and cytotoxicity","volume":"350","author":"Mendez","year":"2008","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejmech.2022.114278_bib30","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1126\/science.8153625","article-title":"Prevention of drug access to bacterial targets: permeability barriers and active efflux","volume":"264","author":"Nikaido","year":"1994","journal-title":"Science"},{"key":"10.1016\/j.ejmech.2022.114278_bib31","doi-asserted-by":"crossref","first-page":"6941","DOI":"10.1021\/acs.jmedchem.9b00288","article-title":"Design of Trp-rich dodecapeptides with broad-spectrum antimicrobial potency and membrane-disruptive mechanism","volume":"62","author":"Lyu","year":"2019","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114278_bib32","doi-asserted-by":"crossref","DOI":"10.1002\/pep2.24122","article-title":"Antimicrobial peptides under clinical investigation","volume":"111","author":"Koo","year":"2019","journal-title":"Peptide Sci."},{"key":"10.1016\/j.ejmech.2022.114278_bib33","doi-asserted-by":"crossref","first-page":"620","DOI":"10.2174\/1568026616666160713143331","article-title":"Antimicrobial peptides under clinical trials","volume":"17","author":"Greber","year":"2017","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114278_bib34","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0924-8579(96)00347-0","article-title":"Meropenem: evaluation of a new generation carbapenem","volume":"8","author":"Blumer","year":"1997","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.ejmech.2022.114278_bib35","doi-asserted-by":"crossref","first-page":"73","DOI":"10.2165\/00003495-199550010-00007","article-title":"Meropenem. A review of its antibacterial activity, pharmacokinetic properties and clinical efficacy","volume":"50","author":"Wiseman","year":"1995","journal-title":"Drugs"},{"key":"10.1016\/j.ejmech.2022.114278_bib36","doi-asserted-by":"crossref","first-page":"2740","DOI":"10.3389\/fmicb.2019.02740","article-title":"Synergy pattern of short cationic antimicrobial peptides against multidrug-resistant Pseudomonas aeruginosa","volume":"10","author":"Ruden","year":"2019","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.ejmech.2022.114278_bib37","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.ijantimicag.2016.09.014","article-title":"Synergistic combinations of polymyxins","volume":"48","author":"Lenhard","year":"2016","journal-title":"Int. J. Antimicrob. Agents"},{"issue":"1","key":"10.1016\/j.ejmech.2022.114278_bib38","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1186\/s12879-021-05995-y","article-title":"Excluded versus included patients in a randomized controlled trial of infections caused by carbapenem-resistant Gram-negative bacteria: relevance to external validity","volume":"31","author":"Daitch","year":"2021","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.ejmech.2022.114278_bib39","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.addr.2004.12.001","article-title":"Tat peptide-mediated cellular delivery: back to basics","volume":"57","author":"Brooks","year":"2005","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ejmech.2022.114278_bib40","doi-asserted-by":"crossref","first-page":"14713","DOI":"10.1021\/bi980809c","article-title":"The preference of tryptophan for membrane interfaces","volume":"37","author":"Yau","year":"1998","journal-title":"Biochemistry"},{"key":"10.1016\/j.ejmech.2022.114278_bib41","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1016\/S0006-3495(98)74054-8","article-title":"Molecular ordering of interfacially localized tryptophan analogs in ester- and ether-lipid bilayers studied by 2H-NMR","volume":"75","author":"Persson","year":"1998","journal-title":"Biophys. J."},{"key":"10.1016\/j.ejmech.2022.114278_bib42","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1021\/acs.jmedchem.1c01782","article-title":"Small amphiphilic peptides: Activity against a broad range of drug-resistant bacteria and structural insight into membranolytic properties","volume":"65","author":"Lohan","year":"2022","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114278_bib43","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1002\/bit.25003","article-title":"Design of short membrane selective antimicrobial peptides containing tryptophan and arginine residues for improved activity, salt-resistance, and biocompatibility","volume":"111","author":"Saravanan","year":"2014","journal-title":"Biotechnol. Bioeng."},{"key":"10.1016\/j.ejmech.2022.114278_bib44","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.actbio.2016.11.061","article-title":"Design and surface immobilization of short anti-biofilm peptides","volume":"49","author":"Mishra","year":"2017","journal-title":"Acta Biomater"},{"key":"10.1016\/j.ejmech.2022.114278_bib45","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1126\/science.271.5246.163","article-title":"Cation-pi interactions in chemistry and biology: a new view of benzene, Phe, Tyr, and Trp","volume":"271","author":"Dougherty","year":"1996","journal-title":"Science"},{"key":"10.1016\/j.ejmech.2022.114278_bib46","doi-asserted-by":"crossref","first-page":"4938","DOI":"10.1128\/JB.185.16.4938-4947.2003","article-title":"Conformation of a bactericidal domain of puroindoline a: structure and mechanism of action of a 13-residue antimicrobial peptide","volume":"185","author":"Jing","year":"2003","journal-title":"J.\u00a0Bacteriol."},{"key":"10.1016\/j.ejmech.2022.114278_bib47","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1093\/jac\/dki236","article-title":"In\u00a0vitro activity of citropin 1.1 alone and in combination with clinically used antimicrobial agents against Rhodococcus equi","volume":"56","author":"Giacometti","year":"2005","journal-title":"J.\u00a0Antimicrob. Chemother."},{"key":"10.1016\/j.ejmech.2022.114278_bib48","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.ijantimicag.2005.06.011","article-title":"In\u00a0vitro activity of MSI-78 alone and in combination with antibiotics against bacteria responsible for bloodstream infections in neutropenic patients","volume":"26","author":"Giacometti","year":"2005","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.ejmech.2022.114278_bib49","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1016\/j.peptides.2009.06.004","article-title":"In\u00a0vitro bactericidal activity of the N-terminal fragment of the frog peptide esculentin-1b (Esc 1-18) in combination with conventional antibiotics against Stenotrophomonas maltophilia","volume":"30","author":"Maisetta","year":"2009","journal-title":"Peptides"},{"key":"10.1016\/j.ejmech.2022.114278_bib50","doi-asserted-by":"crossref","first-page":"358","DOI":"10.3390\/antibiotics4030358","article-title":"Short, synthetic cationic peptides have antibacterial activity against Mycobacterium smegmatis by forming pores in membrane and synergizing with antibiotics","volume":"4","author":"Gupta","year":"2015","journal-title":"Antibiotics"},{"key":"10.1016\/j.ejmech.2022.114278_bib51","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/s12223-016-0479-2","article-title":"Antimicrobial peptide isolated from Bacillus amyloliquefaciens K14 revitalizes its use in combinatorial drug therapy","volume":"62","author":"Regmi","year":"2017","journal-title":"Folia Microbiol."},{"key":"10.1016\/j.ejmech.2022.114278_bib52","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1093\/jac\/44.3.389","article-title":"Ability of azlocillin and tobramycin in combination to delay or prevent resistance development in Pseudomonas aeruginosa","volume":"44","author":"Wu","year":"1999","journal-title":"J.\u00a0Antimicrob. Chemother."},{"key":"10.1016\/j.ejmech.2022.114278_bib53","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1128\/AAC.02434-15","article-title":"Combination effects of antimicrobial peptides","volume":"60","author":"Yu","year":"2016","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2022.114278_bib54","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1016\/j.bbamem.2017.01.037","article-title":"LL-37-derived membrane-active FK-13 analogs possessing cell selectivity, anti-biofilm activity and synergy with chloramphenicol and anti-inflammatory activity","volume":"1859","author":"Rajasekaran","year":"2017","journal-title":"Biochim. Biophys. Acta Biomembr."},{"key":"10.1016\/j.ejmech.2022.114278_bib55","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1097\/CCM.0b013e31819ff137","article-title":"Pseudomonas aeruginosa virulence and therapy: evolving translational strategies","volume":"37","author":"Veesenmeyer","year":"2009","journal-title":"Crit. Care Med."},{"key":"10.1016\/j.ejmech.2022.114278_bib56","doi-asserted-by":"crossref","first-page":"6248","DOI":"10.1128\/AAC.00825-15","article-title":"Mutations in beta-lactamase AmpC increase resistance of Pseudomonas aeruginosa isolates to antipseudomonal cephalosporins","volume":"59","author":"Berrazeg","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2022.114278_bib57","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a025247","article-title":"beta-Lactams and beta-Lactamase Inhibitors: an Overview","volume":"6","author":"Bush","year":"2016","journal-title":"Cold Spring Harb Perspect. Med."},{"key":"10.1016\/j.ejmech.2022.114278_bib58","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2021.611009","article-title":"Trp-containing antibacterial peptides impair quorum sensing and biofilm development in multidrug-resistant Pseudomonas aeruginosa and exhibit synergistic effects with antibiotics","volume":"12","author":"Shang","year":"2021","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.ejmech.2022.114278_bib59","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.resmic.2012.06.001","article-title":"Synergistic effect of antimicrobial peptide arenicin-1 in combination with antibiotics against pathogenic bacteria","volume":"163","author":"Choi","year":"2012","journal-title":"Res. Microbiol."},{"key":"10.1016\/j.ejmech.2022.114278_bib60","doi-asserted-by":"crossref","first-page":"517","DOI":"10.7164\/antibiotics.44.517","article-title":"The outer membrane permeability-increasing action of deacylpolymyxins","volume":"44","author":"Viljanen","year":"1991","journal-title":"J.\u00a0Antibiot. (Tokyo)"},{"key":"10.1016\/j.ejmech.2022.114278_bib61","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.3892\/etm.2013.1231","article-title":"Synergistic effect of clinically used antibiotics and peptide antibiotics against Gram-positive and Gram-negative bacteria","volume":"6","author":"Zhou","year":"2013","journal-title":"Exp. Ther. Med."},{"key":"10.1016\/j.ejmech.2022.114278_bib62","doi-asserted-by":"crossref","first-page":"353","DOI":"10.3389\/fmicb.2013.00353","article-title":"Antibiotic development challenges: the various mechanisms of action of antimicrobial peptides and of bacterial resistance","volume":"4","author":"Guilhelmelli","year":"2013","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.ejmech.2022.114278_bib63","first-page":"43","article-title":"Antimicrobial peptide from Bacillus subtilis CSB138: characterization, killing kinetics, and synergistic potency","volume":"20","author":"Regmi","year":"2017","journal-title":"Int. Microbiol."},{"key":"10.1016\/j.ejmech.2022.114278_bib64","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1093\/protein\/5.3.213","article-title":"The functions of tryptophan residues in membrane proteins","volume":"5","author":"Schiffer","year":"1992","journal-title":"Protein Eng"},{"key":"10.1016\/j.ejmech.2022.114278_bib65","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1093\/jac\/31.5.681","article-title":"Inhibition of Pseudomonas aeruginosa virulence factors by subinhibitory concentrations of azithromycin and other macrolide antibiotics","volume":"31","author":"Molinari","year":"1993","journal-title":"J.\u00a0Antimicrob. Chemother."},{"key":"10.1016\/j.ejmech.2022.114278_bib66","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1128\/AAC.41.4.771","article-title":"Improved activity of a synthetic indolicidin analog","volume":"41","author":"Falla","year":"1997","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2022.114278_bib67","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2019.02719","article-title":"Synergistic antibacterial activity of designed Trp-containing antibacterial peptides in combination with antibiotics against multidrug-resistant Staphylococcus epidermidis","volume":"10","author":"Shang","year":"2019","journal-title":"Front. Microbiol."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523422001805?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523422001805?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T14:39:00Z","timestamp":1759329540000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523422001805"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5]]},"references-count":67,"alternative-id":["S0223523422001805"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2022.114278","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2022,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Amphiphilic cyclic peptide [W4KR5]-Antibiotics combinations as broad-spectrum antimicrobial agents","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2022.114278","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"114278"}}